top of page
Aura Application Note 　　　　アプリケーションノート
App Note 1：See What’s Really In Your Formulation With Backgrounded Membrane Imaging
App Note 2：Accurate Subvisible Particle Analysis With 10x Less Sample
App Note 3：A New Method for Measuring Particulates in Protein Drug Formulations with Complex Excipients
App Note 4：Sized Right For Particle Analysis
App Note 5：High Throughput Measurement of Compound Solubility and Physical Form with BMI
App Note 6：Are You Missing the Bigger Picture with Your AAV Analytics?
App Note 7：Protein Aggregate Identification with FMM: Rapidly Distinguish Protein from Non-Protein Particles in Biologic Formulations
App Note 8：AAV Aggregate Quantitation and Identification with the Aura System
App Note 9： USP Compendial Particle Measurements with the Aura System
App Note 10：Detect Specific Protein Aggregates in Biologic Formulations with the Aura Immunoassay
App Note 11：High-Throughput Detection of Degraded Polysorbate with FMM
App Note 12：Detect, Identify, and Characterize Cellular versus Non-cellular Aggregates with the Aura CL
App Note 13：Evaluate Cell Therapy Product Purity with Aura CL
App Note 14：Identify and Characterize Particles in the Visible Size Range with Aura
App Note 15： Accurate, High-Throughput Cell Viability and Purity Measurements with Aura CL
App Note 16： Is Your AAV Payload Impacting Stability? Find out with Aura GT
App Note 17：Identify Optimal Biologic Candidates: Low Volume, Early Stage Developability Assessment with Aura PTx
App Note 18：Identify Stable Biologic Candidates During Cell Line Development With Aura PTx
App Note 19：Analysis of Subvisible and Visible Aggregation in Lentiviral Vectors with Aura GT
App Note 20： Accurate Particles Characterization in Lipid Nanoparticle Therapies
App Note 21： Subvisible Particles: Why Don’t I Just Filter My Biologic Samples?
App Note 22： Detecting Glass Particles – Making the Invisible Visible to Avoid the Leading Cause of Drug Recalls
bottom of page